Found launched in 2019 with a different positioning than Calibrate or other GLP-1 weight loss platforms — a more flexible monthly model with broader medication options, leaning toward a “right tool for your biology” framing rather than a one-size-fits-all GLP-1 push. The platform prescribes GLP-1 medications, off-label uses of bupropion-naltrexone, metformin, topiramate, and others depending on patient profile. This found weight loss review covers 2026 pricing, the assessment-and-prescribing model, what’s included, and how Found compares to Calibrate, Noom Med, Ro, and Hims weight loss programs. The headline: Found is more flexible than Calibrate but lighter on coaching, with broader medication options that fit more patient profiles.
How Found’s program works
Found’s intake includes a comprehensive metabolic health assessment covering hormonal factors, sleep, stress, behavioral patterns, prior weight loss history, and medical contraindications. A clinician (physician or nurse practitioner) reviews the assessment and selects from a broader formulary than most competitors — GLP-1 medications when appropriate, but also metformin, bupropion, naltrexone, topiramate, contrave (the bupropion-naltrexone combination), and others.
Ongoing care includes monthly clinician check-ins, asynchronous messaging with the prescriber, access to behavioral coaching content through the app, and optional one-on-one coaching at higher tiers. The model is more medication-agnostic than Calibrate, recognizing that not every patient is a GLP-1 candidate and that for some patients, off-label use of older weight loss medications produces better outcomes at lower cost. For broader context, see our telehealth guide and best telehealth for weight loss roundup.
Found pricing in 2026
Found’s monthly subscription is $99-129 per month for the standard program, with annual prepay options reducing the per-month cost. Medication is separate. Generic medications like metformin, bupropion, and naltrexone often run $10-30 per month with insurance or through the platform’s pharmacy partner. Branded GLP-1s like Wegovy and Zepbound clear $1,000+ per month without insurance, with insurance coverage handling most of the cost when applicable.
The flexible monthly subscription model is meaningfully different from Calibrate’s 12-month upfront commitment. Patients can pause or cancel at any time, which reduces the financial barrier to entry. Found doesn’t bill insurance for the program fee but coordinates GLP-1 prescriptions for insurance billing through preferred pharmacies. See our healthcare costs guide for cost context against typical weight loss program pricing.
What Found prescribes that other platforms don’t
Found’s broader formulary is the primary clinical differentiator. The platform routinely prescribes:
- Metformin off-label for weight loss in patients with insulin resistance markers
- Bupropion (Wellbutrin) off-label for weight loss, particularly when comorbid with depression
- Naltrexone, often combined with bupropion (Contrave is the FDA-approved combination)
- Topiramate off-label, often combined with phentermine (Qsymia is the FDA-approved combination)
- GLP-1 medications including Wegovy, Zepbound, and off-label use of others
This formulary breadth matters because not every patient responds best to GLP-1s, and not every patient can afford or access them. A patient with insulin resistance, mild obesity, and budget constraints may do well on metformin at $5-15 per month. A patient with comorbid depression may benefit from bupropion. The “match medication to patient” approach is closer to traditional bariatric medicine than to platforms that lead with GLP-1 marketing.
The coaching component
Found’s coaching is lighter than Calibrate’s but real. The standard plan includes app-based behavioral content covering nutrition, exercise, sleep, and emotional health, with optional weekly check-ins through messaging. Higher-tier plans add one-on-one coaching sessions, but the default experience is closer to “structured medication management with educational content” than Calibrate’s “intensive coaching with medication.”
For patients who want clinical medical management without intensive coaching, Found’s lighter approach is genuinely a feature. For patients who need accountability and structured behavior change support to succeed, Calibrate’s heavier coaching model produces better outcomes. The honest comparison is that Found is closer to traditional outpatient bariatric medicine while Calibrate is closer to a structured weight loss program. Both are legitimate models with different value propositions. See our detailed Calibrate vs Found head-to-head for the full comparison.
Found’s clinical infrastructure
Found employs board-certified physicians and nurse practitioners with bariatric medicine training. The clinical assessment is thorough — the intake covers metabolic markers, hormonal factors, behavioral history, and contraindications in more depth than typical DTC weight loss platforms. Clinicians use the assessment data to inform medication selection rather than defaulting to a single drug.
Lab work is offered as an add-on. Patients can order metabolic labs (lipid panel, A1c, comprehensive metabolic panel, thyroid) through Found’s lab partner and have results integrated into the clinical chart. This is more sophisticated than platforms that prescribe based purely on patient-reported information. The Obesity Medicine Association provides professional standards for medical weight loss; Found’s clinical model aligns more closely with these standards than most DTC competitors.
Where Found falls short
The lighter coaching model means patients who need behavior change support don’t get as much through Found as through Calibrate or Noom. For patients with strong self-direction and clear medical needs, this is a feature; for patients who’ve failed prior weight loss attempts due to lifestyle factors, the lighter coaching may not move outcomes enough.
Insurance integration is limited like most DTC platforms. The program fee is out-of-pocket, and while Found helps coordinate GLP-1 insurance prescriptions, complex prior authorization processes are still patient-driven. Customer service complaints around medication delays, particularly for compounded options, have been documented in 2024-2025. The 2025 changes to the FDA semaglutide shortage list affected which compounded options remain available, and the experience of patients on compounded medications was disrupted during this transition.
Found vs Calibrate, Noom Med, Ro, and Hims
Compared to Calibrate, Found is more flexible (monthly vs 12-month) and has broader medication options but lighter coaching. Compared to Noom Med, Found has stronger clinical infrastructure while Noom integrates a more comprehensive behavioral platform. See Found vs Noom for the head-to-head and Noom vs Calibrate for the broader behavioral coaching comparison.
Compared to Ro and Hims weight loss, Found has substantially more comprehensive clinical assessment and broader medication options. Ro and Hims primarily prescribe GLP-1 medications with minimal alternative formulary; Found’s medication-agnostic approach fits a wider range of patient profiles. See Ro vs Hims weight loss for the GLP-1-focused comparison.
Frequently Asked Questions
Does Found prescribe Wegovy and Zepbound?
Yes. Found prescribes FDA-approved GLP-1 medications including Wegovy and Zepbound for eligible patients. The platform also prescribes off-label medications and older weight loss drugs depending on the clinical assessment.
Does Found take insurance?
Found does not bill insurance for the program fee. The platform coordinates GLP-1 prescriptions through preferred pharmacies where insurance coverage applies for the medication itself. Patients should verify their plan’s GLP-1 coverage independently.
Is Found cheaper than Calibrate?
Generally yes for the program fee. Found’s $99-129 per month is substantially less than Calibrate’s $1,649 12-month commitment. Total cost depends on medication choice and insurance coverage, which can be similar or different across the two platforms.
Can I cancel Found anytime?
Yes. The monthly subscription can be canceled at any time through the account portal. Cancellation takes effect at the end of the current billing cycle.
What medications does Found offer besides GLP-1s?
Metformin, bupropion (Wellbutrin), naltrexone, Contrave (bupropion-naltrexone combination), topiramate, Qsymia (phentermine-topiramate combination), and others depending on clinical assessment. The broader formulary is one of Found’s primary differentiators.
The bottom line on Found
Found is the most flexible medical weight loss platform in the DTC market, with the broadest medication formulary and a monthly subscription model that doesn’t require upfront commitment. The clinical assessment is thorough and the medication-agnostic approach fits a wider range of patients than GLP-1-only platforms. The lighter coaching is a feature for self-directed patients and a weakness for those needing behavior change support. For patients with insulin resistance, mild obesity, or budget constraints where GLP-1s aren’t the right first move, Found’s broader formulary makes it a stronger fit than Calibrate, Ro, or Hims weight loss programs.